- CConnexion
RééDOC
75 Boulevard Lobau 54042 NANCY cedex Christelle Grandidier Documentaliste 03 83 52 67 64 0
|
Defining the optimum upper heart rate limit during exercise - A study in pacemaker patients with heart failure
KINDERMANN M; SCHWAAB B; FINKLER N
EUR HEART J , 2002, vol. 23, n° 16, p. 1301-1308 Doc n°: 107080 Localisation : Documentation IRR Descripteurs : FA32 - TROUBLES DU RYTHME CARDIAQUE There is no non-invasive method to determine the individual optimum of maximum exercise heart rate. Knowledge of this value is of particular interest in patients with structural heart disease who are prone to tachycardia intolerance. The purpose of this study was to define the optimal maximum heart rate using cardiopulmonary exercise testing and exercise Doppler echocardiography and to compare the results of both approaches. Methods and Results In 49 pacemaker patients with chronotropic incompetence, the optimum upper heart rate limit was determined using cardiopulmonary exercise testing and exercise Doppler echocardiography. The optimum upper rate limit was given by the highest pacing rate which still produced an increase in oxygen consumption, or by that pacing rate which was linked to the lowest value for the Doppler-derived myocardial performance index. In patients with normal left ventricular ejection fraction (greater than or equal to 55%) the optimum upper rate limit was 86% of age-predicted maximum heart rate, in patients with left ventriuclar dysfunction (ejection fraction less than or equal to 45%) it was 75% of the age-predicted maximum rate (P = 0.004). The optimum upper rate limit, as defined by cardiopulmonary exercise testing and exercise Doppler echocardiography, were closely correlated (P < 0.0001) with a mean deviation of 6 +/- 6 beats . Min(-1). Conclusion Cardiopulmonary exercise testing and exercise Doppler echocardiography are valuable tools which help to determine the optimum upper rate limit in order to avoid excess heart rates in heart failure patients. The application of these methods is not limited to pacemaker patients but may be helpful in therapeutic interventions with chronotropic drugs. (C) 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved. Langue : ANGLAIS Tiré à part : OUI Identifiant basis : 2003225161 |
0
|